Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study

Long-term use of statins has been reported to reduce the risk of death in patients with lung cancer. This study investigated the effect of statin use among patients with lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) therapy. A nationwide, population-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Ming-Szu, Chen, I-Chuan, Lee, Chuan-Pin, Huang, Ru-Jiun, Chen, Pau-Chung, Tsai, Ying-Huang, Yang, Yao-Hsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291515/
https://www.ncbi.nlm.nih.gov/pubmed/28158206
http://dx.doi.org/10.1371/journal.pone.0171137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291515/
https://www.ncbi.nlm.nih.gov/pubmed/28158206
http://dx.doi.org/10.1371/journal.pone.0171137

Ejemplares similares